RU2017135072A3 - - Google Patents
Download PDFInfo
- Publication number
- RU2017135072A3 RU2017135072A3 RU2017135072A RU2017135072A RU2017135072A3 RU 2017135072 A3 RU2017135072 A3 RU 2017135072A3 RU 2017135072 A RU2017135072 A RU 2017135072A RU 2017135072 A RU2017135072 A RU 2017135072A RU 2017135072 A3 RU2017135072 A3 RU 2017135072A3
- Authority
- RU
- Russia
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/555—Heterocyclic compounds containing heavy metals, e.g. hemin, hematin, melarsoprol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/243—Platinum; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0078—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M11/00—Sprayers or atomisers specially adapted for therapeutic purposes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M15/00—Inhalators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2202/00—Special media to be introduced, removed or treated
- A61M2202/06—Solids
- A61M2202/064—Powder
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562132374P | 2015-03-12 | 2015-03-12 | |
| US62/132,374 | 2015-03-12 | ||
| PCT/US2016/021843 WO2016145234A2 (en) | 2015-03-12 | 2016-03-10 | Use of mk2 inhibitor peptide-containing compositions for treating non-small cell lung cancer with same |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| RU2017135072A RU2017135072A (ru) | 2019-04-10 |
| RU2017135072A3 true RU2017135072A3 (ru) | 2019-09-30 |
Family
ID=56880599
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2017135072A RU2017135072A (ru) | 2015-03-12 | 2016-03-10 | Применение пептидсодержащих композиций ингибитора mk2 для лечения немелкоклеточного рака легкого |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US9999655B2 (ru) |
| EP (1) | EP3268022A4 (ru) |
| JP (1) | JP2018512401A (ru) |
| KR (1) | KR20170125090A (ru) |
| CN (1) | CN107921082A (ru) |
| AU (1) | AU2016229017A1 (ru) |
| BR (1) | BR112017019343A2 (ru) |
| CA (1) | CA2978941A1 (ru) |
| HK (1) | HK1249433A1 (ru) |
| MX (1) | MX2017011633A (ru) |
| RU (1) | RU2017135072A (ru) |
| SG (1) | SG11201707281QA (ru) |
| WO (1) | WO2016145234A2 (ru) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10617717B2 (en) | 2016-12-04 | 2020-04-14 | Expression Pathology, Inc. | Methods of treating lung cancer by predicting responders to cisplatin-pemetrexed combination therapy |
| US11408887B2 (en) | 2017-05-22 | 2022-08-09 | The National Institute for Biotechnology in the Negev Ltd. | Biomarkers for diagnosis of lung cancer |
| US10952799B2 (en) * | 2017-05-31 | 2021-03-23 | Covidien Lp | Systems and methods for navigational bronchoscopy and selective drug delivery |
| US20190134153A1 (en) * | 2017-06-12 | 2019-05-09 | Moerae Matrix, Inc. | Immunomodulatory effect of inhaled kinase inhibitor peptides in lung |
| EP3806880A1 (en) * | 2018-06-12 | 2021-04-21 | Université de Genève | Peptidic protein kinase c inhibitors and uses thereof |
| US11195062B2 (en) | 2018-11-15 | 2021-12-07 | Nantomics, Llc | Classification based on characterization analysis methods and systems |
| CA3147575A1 (en) | 2019-07-29 | 2021-02-04 | Yeda Research And Development Co. Ltd. | Methods of treating and diagnosing lung cancer |
| CN113261532A (zh) * | 2020-02-17 | 2021-08-17 | 中山大学 | 一种肺癌动物模型的构建方法 |
| EP4114411A4 (en) * | 2020-03-02 | 2024-04-24 | Washington University St Louis | COMPOSITIONS AND METHODS FOR THE TREATMENT OF PANCREATIC CANCER |
| JP2023551798A (ja) * | 2020-11-18 | 2023-12-13 | ロンザ・ベンド・インコーポレーテッド | 血管新生阻害剤を含む吸入可能な乾燥粉末製剤 |
Family Cites Families (33)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1521000A (en) | 1975-06-13 | 1978-08-09 | Syntex Puerto Rico Inc | Inhalation device |
| US4227522A (en) | 1978-09-05 | 1980-10-14 | Syntex Puerto Rico, Inc. | Inhalation device |
| US4192309A (en) | 1978-09-05 | 1980-03-11 | Syntex Puerto Rico, Inc. | Inhalation device with capsule opener |
| CA1224992A (en) | 1982-10-08 | 1987-08-04 | Robert E. Newell | Device for administering medicament to patients |
| US4778054A (en) | 1982-10-08 | 1988-10-18 | Glaxo Group Limited | Pack for administering medicaments to patients |
| GR861995B (en) | 1985-07-30 | 1986-11-04 | Glaxo Group Ltd | Devices for administering medicaments to patients |
| JPH05963A (ja) | 1990-04-13 | 1993-01-08 | Toray Ind Inc | ポリペプチド類組成物 |
| US6331318B1 (en) | 1994-09-30 | 2001-12-18 | Emisphere Technologies Inc. | Carbon-substituted diketopiperazine delivery systems |
| US5352461A (en) | 1992-03-11 | 1994-10-04 | Pharmaceutical Discovery Corporation | Self assembling diketopiperazine drug delivery system |
| WO1993022443A1 (en) | 1992-04-24 | 1993-11-11 | Sri International | In vivo homologous sequence targeting in eukaryotic cells |
| US6582728B1 (en) | 1992-07-08 | 2003-06-24 | Inhale Therapeutic Systems, Inc. | Spray drying of macromolecules to produce inhaleable dry powders |
| PT733059E (pt) | 1993-12-09 | 2001-03-30 | Univ Jefferson | Compostos e metodos para mutacoes dirigidas ao local em celulas eucarioticas |
| US6428771B1 (en) | 1995-05-15 | 2002-08-06 | Pharmaceutical Discovery Corporation | Method for drug delivery to the pulmonary system |
| WO2000059476A1 (en) | 1999-04-05 | 2000-10-12 | Pharmaceutical Discovery Corporation | Methods for fine powder formation |
| PT1196430E (pt) | 1999-06-29 | 2012-04-18 | Mannkind Corp | Purificação e estabilização de péptidos e proteínas em agentes farmacêuticos |
| US8853266B2 (en) * | 2001-12-06 | 2014-10-07 | University Of Tennessee Research Foundation | Selective androgen receptor modulators for treating diabetes |
| US20060039985A1 (en) | 2004-04-27 | 2006-02-23 | Bennett David B | Methotrexate compositions |
| DK1786784T3 (da) | 2004-08-20 | 2011-02-14 | Mannkind Corp | Katalyse af diketopiperazinsyntese |
| JP2008510825A (ja) | 2004-08-23 | 2008-04-10 | マンカインド コーポレイション | ホスホジエステラーゼ５型の阻害剤の肺送達 |
| ES2543007T3 (es) | 2004-08-23 | 2015-08-13 | Mannkind Corporation | Micropartículas que comprenden sales de dicetopiperazina para la administración de fármacos |
| IN2014DN09128A (ru) | 2005-09-14 | 2015-07-10 | Mannkind Corp | |
| US8039431B2 (en) | 2006-02-22 | 2011-10-18 | Mannkind Corporation | Method for improving the pharmaceutic properties of microparticles comprising diketopiperazine and an active agent |
| DK2155228T3 (da) | 2007-01-10 | 2014-07-07 | Purdue Research Foundation | Polypeptidinhibitorer af HSP27-kinase og anvendelser herfor |
| DK2185698T3 (en) * | 2007-08-07 | 2015-07-27 | Purdue Research Foundation | Kinase Inhibitors and Uses thereof |
| CN102256613B (zh) | 2008-10-20 | 2014-09-10 | 莫伊莱麦屈克斯公司 | 用于治疗或者预防粘连的多肽 |
| US9327008B2 (en) | 2008-12-10 | 2016-05-03 | Purdue Research Foundation | Cell-permeant peptide-based inhibitor of kinases |
| WO2011017132A2 (en) | 2009-07-27 | 2011-02-10 | Purdue Research, Foundation | Mk2 inhibitor compositions and methods to enhance neurite outgrowth, neuroprotection, and nerve regeneration |
| US20130115256A1 (en) | 2010-05-24 | 2013-05-09 | Cynthia Lander | Methods for treating or preventing vascular graft failure |
| US10105356B2 (en) * | 2011-01-31 | 2018-10-23 | Avalyn Pharma Inc. | Aerosol pirfenidone and pyridone analog compounds and uses thereof |
| CN104302310A (zh) | 2011-04-12 | 2015-01-21 | 莫伊莱麦屈克斯公司 | 用于预防或治疗以成纤维细胞异常增殖及细胞外基质沉积为特征的疾病、病状或病程的组合物和方法 |
| US9890200B2 (en) * | 2011-04-12 | 2018-02-13 | Moerae Matrix, Inc. | Compositions and methods for preventing or treating diseases, conditions, or processes characterized by aberrant fibroblast proliferation and extracellular matrix deposition |
| EP3467124A1 (en) | 2012-06-06 | 2019-04-10 | Fundació Institut de Recerca Biomèdica IRB (Barcelona) | Method for the diagnosis, prognosis and treatment of lung cancer metastasis |
| US20140072613A1 (en) | 2012-09-10 | 2014-03-13 | Cynthia Lander | Compositions and Methods for Treating Cutaneous Scarring |
-
2016
- 2016-03-10 US US15/066,976 patent/US9999655B2/en not_active Expired - Fee Related
- 2016-03-10 CN CN201680022723.9A patent/CN107921082A/zh active Pending
- 2016-03-10 BR BR112017019343A patent/BR112017019343A2/pt not_active Application Discontinuation
- 2016-03-10 WO PCT/US2016/021843 patent/WO2016145234A2/en active Application Filing
- 2016-03-10 SG SG11201707281QA patent/SG11201707281QA/en unknown
- 2016-03-10 KR KR1020177028070A patent/KR20170125090A/ko unknown
- 2016-03-10 EP EP16762545.8A patent/EP3268022A4/en not_active Withdrawn
- 2016-03-10 JP JP2017548089A patent/JP2018512401A/ja active Pending
- 2016-03-10 AU AU2016229017A patent/AU2016229017A1/en not_active Abandoned
- 2016-03-10 MX MX2017011633A patent/MX2017011633A/es unknown
- 2016-03-10 CA CA2978941A patent/CA2978941A1/en not_active Abandoned
- 2016-03-10 RU RU2017135072A patent/RU2017135072A/ru not_active Application Discontinuation
-
2018
- 2018-07-13 HK HK18109079.5A patent/HK1249433A1/zh unknown
Also Published As
| Publication number | Publication date |
|---|---|
| JP2018512401A (ja) | 2018-05-17 |
| HK1249433A1 (zh) | 2018-11-02 |
| WO2016145234A2 (en) | 2016-09-15 |
| AU2016229017A1 (en) | 2017-09-28 |
| CN107921082A (zh) | 2018-04-17 |
| CA2978941A1 (en) | 2016-09-15 |
| US9999655B2 (en) | 2018-06-19 |
| SG11201707281QA (en) | 2017-10-30 |
| US20160263187A1 (en) | 2016-09-15 |
| EP3268022A2 (en) | 2018-01-17 |
| MX2017011633A (es) | 2017-11-02 |
| RU2017135072A (ru) | 2019-04-10 |
| EP3268022A4 (en) | 2018-11-21 |
| BR112017019343A2 (pt) | 2018-05-02 |
| WO2016145234A3 (en) | 2016-11-03 |
| KR20170125090A (ko) | 2017-11-13 |
Similar Documents
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA92 | Acknowledgement of application withdrawn (lack of supplementary materials submitted) |
Effective date: 20200806 |